VIVUS LLC

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Drug Interaction Study of Avanafil and Enalapril or Amlodipine

Phase 1

Completed

Conditions: Erectile Dysfunction

Interventions: Drug: avanafil and enalapril
Drug: avanafil and amlodipine

First Posted Date: 2010-05-05

Last Posted Date: 2011-08-10

Lead Sponsor: VIVUS LLC

Target Recruit Count: 48

Registration Number: NCT01117038

Locations: 🇺🇸
Celerion, Tempe, Arizona, United States

Hemodynamic Study of Avanafil and Two α-Adrenergic Blockers,Doxazosin and Tamsulosin

Phase 1

Completed

Conditions: Erectile Dysfunction

Interventions: Drug: Tamsulosin and avanafil
Drug: Doxazosin and avanafil

First Posted Date: 2010-04-08

Last Posted Date: 2011-01-07

Lead Sponsor: VIVUS LLC

Target Recruit Count: 48

Registration Number: NCT01100021

Locations: 🇺🇸
MDS Pharma Services Inc.,, Tempe, Arizona, United States

A Pharmacokinetic (PK) Study to Compare the Absorption of Two Formulations of Transdermal Testosterone Spray and Intrinsa®

Phase 1

Terminated

Conditions: Hypoactive Sexual Desire Disorder

Interventions: Drug: Testosterone Spray 5% and 1%
Drug: Intrinsa® Patch and Testosterone Spray 5%
Drug: Intrinsa® Patch and Testosterone Spray 1%

First Posted Date: 2010-03-31

Last Posted Date: 2011-06-08

Lead Sponsor: VIVUS LLC

Target Recruit Count: 16

Registration Number: NCT01096329

Locations: 🇺🇸
MDS Pharma Services, Tempe, Arizona, United States

Study the Effect of Avanafil on the Pharmacodynamics and Pharmacokinetics of Warfarin in Healthy Male Subjects

Phase 1

Completed

Conditions: Erectile Dysfunction

Interventions: Drug: 200 mg Avanafil
Drug: Placebo

First Posted Date: 2010-03-30

Last Posted Date: 2011-01-07

Lead Sponsor: VIVUS LLC

Target Recruit Count: 24

Registration Number: NCT01095588

Assess the Effect of Food on Avanafil Pharmacokinetic (PK), to Compare 2 Oral Formulations of Avanafil,and Investigate Dose Proportionality in Healthy Male Subjects

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Avanafil

First Posted Date: 2010-03-30

Last Posted Date: 2011-01-07

Lead Sponsor: VIVUS LLC

Target Recruit Count: 24

Registration Number: NCT01095601

To Assess the Safety of Avanafil in Healthy and Hepatically Impaired Male Subjects.

Phase 1

Completed

Conditions: Erectile Dysfunction

Interventions: Drug: avanafil

First Posted Date: 2010-01-22

Last Posted Date: 2011-01-07

Lead Sponsor: VIVUS LLC

Target Recruit Count: 27

Registration Number: NCT01054430

A Phase I Crossover Study of the Hemodynamic Interactions of Avanafil & Alcohol in Healthy Male Subjects.

Phase 1

Completed

Conditions: Erectile Dysfunction

Interventions: Drug: avanafil
Other: alcohol

First Posted Date: 2010-01-22

Last Posted Date: 2011-01-07

Lead Sponsor: VIVUS LLC

Target Recruit Count: 15

Registration Number: NCT01054859

To Compare the Pharmacokinetics of Avanafil in Subjects With Mild and Moderate Renal Impairment to Subjects With Normal Renal Function.

Phase 1

Completed

Conditions: Renal

Interventions: Drug: avanafil

First Posted Date: 2010-01-22

Last Posted Date: 2011-01-07

Lead Sponsor: VIVUS LLC

Target Recruit Count: 24

Registration Number: NCT01054261

A Pharmacokinetic Study of Avanfil in Healthy Young Male Subjects

Phase 1

Completed

Conditions: Avanfil ADME
Semen Exposure
Sperm Function

Interventions: Drug: avanafil 200mg

First Posted Date: 2009-06-05

Last Posted Date: 2011-01-07

Lead Sponsor: VIVUS LLC

Target Recruit Count: 32

Registration Number: NCT00914511

Locations: 🇺🇸
MDS Pharma Services, Tempe, Arizona, United States

Research Evaluating an Investigational Medication for Erectile Dysfunction - Post-Prostatectomy

Phase 3

Completed

Conditions: Erectile Dysfunction

Interventions: Drug: Placebo
Drug: Avanafil

First Posted Date: 2009-05-07

Last Posted Date: 2012-10-01

Lead Sponsor: VIVUS LLC

Target Recruit Count: 298

Registration Number: NCT00895011

Locations: 🇺🇸
Research Site, Richmond, Virginia, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy